TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

WOLVERINE ASSET MANAGEMENT LLC's Holding History (CIK: 0001279891)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 13,366,000 Value ($000) $13,300 Avg Close — Range —
Q4 2024
Shares 40,692,000 Value ($000) $38,450 Avg Close — Range —
Q3 2024
Shares 45,400,000 Value ($000) $39,165 Avg Close — Range —
Q2 2024
Shares 45,400,000 Value ($000) $29,410 Avg Close — Range —
Q1 2024
Shares 45,400,000 Value ($000) $28,992 Avg Close — Range —
Q4 2023
Shares 45,400,000 Value ($000) $29,749 Avg Close — Range —
Q3 2023
Shares 45,400,000 Value ($000) $29,374 Avg Close — Range —
Q2 2023
Shares 45,400,000 Value ($000) $36,909 Avg Close — Range —
Q1 2023
Shares 37,900,000 Value ($000) $37,318 Avg Close — Range —
Q4 2022
Shares 37,900,000 Value ($000) $34,561 Avg Close — Range —
Q3 2022
Shares 37,900,000 Value ($000) $38,693 Avg Close — Range —
Q2 2022
Shares 37,000,000 Value ($000) $37,277 Avg Close — Range —
Q1 2022
Shares 34,000,000 Value ($000) $36,271 Avg Close — Range —